Search research articles
Contact Us
Filters
Showing results (351-360 of 604) with videos related to
Page
of 61
Sort By:
European Journal of Neurology
|
August 22, 2008
Clinical risk-benefit assessment of dopamine agonists
J C Möller, K M Eggert, M Unger, et al.
Therapeutic Advances in Neurological Disorders
|
December 15, 2025
Alterations of fecal short-chain fatty acids solely in the course of multiple sclerosis: rethinking the gut-brain axis in the early stages of MS
Jakob Stögbauer, Niklas Kämpfer, Anouck Becker-Dorison, et al.
Blood
|
April 18, 1998
Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria
T K Held, M E Mielke, M Chedid, et al.
Der Pathologe
|
July 1, 1988
[Morphologic studies of the placentas of HIV-positive mothers]
E Jimenez, M Unger, M Vogel, et al.
Cancer
|
November 8, 2017
Estimating global treatment toxicity burden from adverse-event data
Shing M Lee, Dawn L Hershman, Jieling Miao, et al.
BMC Public Health
|
March 14, 2025
Healthcare utilization in the departments of obstetrics and gynecology during the first two years of the COVID-19 pandemic: time series analysis in Jining, China
Yao He, Hong Xiao, Fang Liu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 29, 2020
Economic Evaluations in National Cancer Institute-Sponsored Network Cancer Clinical Trials
Van T Nghiem, Riha Vaidya, Gary H Lyman, et al.
JAMA Oncology
|
March 12, 2016
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials
Joseph M Unger, William E Barlow, Scott D Ramsey, et al.
JNCI Cancer Spectrum
|
December 13, 2021
Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms
N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2005
New treatment options have changed the survival of patients with follicular lymphoma
Richard I Fisher, Michael LeBlanc, Oliver W Press, et al.
Page
of 61
Search research articles
Search
Showing results (351-360 of 604) with videos related to
Sort By:
Page
of 61
European Journal of Neurology
|
August 22, 2008
Clinical risk-benefit assessment of dopamine agonists
J C Möller, K M Eggert, M Unger, et al.
Therapeutic Advances in Neurological Disorders
|
December 15, 2025
Alterations of fecal short-chain fatty acids solely in the course of multiple sclerosis: rethinking the gut-brain axis in the early stages of MS
Jakob Stögbauer, Niklas Kämpfer, Anouck Becker-Dorison, et al.
Blood
|
April 18, 1998
Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria
T K Held, M E Mielke, M Chedid, et al.
Der Pathologe
|
July 1, 1988
[Morphologic studies of the placentas of HIV-positive mothers]
E Jimenez, M Unger, M Vogel, et al.
Cancer
|
November 8, 2017
Estimating global treatment toxicity burden from adverse-event data
Shing M Lee, Dawn L Hershman, Jieling Miao, et al.
BMC Public Health
|
March 14, 2025
Healthcare utilization in the departments of obstetrics and gynecology during the first two years of the COVID-19 pandemic: time series analysis in Jining, China
Yao He, Hong Xiao, Fang Liu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 29, 2020
Economic Evaluations in National Cancer Institute-Sponsored Network Cancer Clinical Trials
Van T Nghiem, Riha Vaidya, Gary H Lyman, et al.
JAMA Oncology
|
March 12, 2016
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials
Joseph M Unger, William E Barlow, Scott D Ramsey, et al.
JNCI Cancer Spectrum
|
December 13, 2021
Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms
N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2005
New treatment options have changed the survival of patients with follicular lymphoma
Richard I Fisher, Michael LeBlanc, Oliver W Press, et al.
Page
of 61